Laura Elisabeth Dichtel, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Human Growth Hormone | 6 | 2022 | 642 | 2.420 |
Why?
|
Overweight | 10 | 2024 | 2417 | 1.890 |
Why?
|
Pregnanolone | 3 | 2020 | 67 | 1.400 |
Why?
|
Liver Cirrhosis | 6 | 2024 | 1935 | 1.010 |
Why?
|
Acromegaly | 4 | 2022 | 310 | 1.000 |
Why?
|
Insulin-Like Growth Factor I | 7 | 2023 | 1935 | 0.950 |
Why?
|
Obesity | 13 | 2024 | 12947 | 0.880 |
Why?
|
Myostatin | 1 | 2024 | 129 | 0.870 |
Why?
|
Dehydroepiandrosterone | 1 | 2022 | 258 | 0.760 |
Why?
|
Dehydroepiandrosterone Sulfate | 2 | 2022 | 241 | 0.710 |
Why?
|
Glucagon-Like Peptides | 1 | 2021 | 153 | 0.680 |
Why?
|
Hydrocortisone | 4 | 2022 | 1819 | 0.670 |
Why?
|
Body Composition | 7 | 2020 | 2426 | 0.660 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2019 | 190 | 0.610 |
Why?
|
Insulin-Like Growth Factor Binding Protein 2 | 1 | 2018 | 68 | 0.600 |
Why?
|
Androstane-3,17-diol | 1 | 2017 | 20 | 0.600 |
Why?
|
Adrenal Insufficiency | 1 | 2019 | 194 | 0.580 |
Why?
|
Pituitary Diseases | 2 | 2016 | 135 | 0.570 |
Why?
|
Liver Neoplasms | 3 | 2024 | 4317 | 0.560 |
Why?
|
Liver | 8 | 2024 | 7528 | 0.550 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2018 | 416 | 0.520 |
Why?
|
Cushing Syndrome | 1 | 2016 | 241 | 0.480 |
Why?
|
Affective Symptoms | 1 | 2017 | 417 | 0.470 |
Why?
|
Testosterone | 3 | 2020 | 2472 | 0.470 |
Why?
|
Thinness | 1 | 2017 | 490 | 0.450 |
Why?
|
Bone Density | 4 | 2022 | 3551 | 0.440 |
Why?
|
Anorexia Nervosa | 3 | 2017 | 1361 | 0.440 |
Why?
|
Insulin Resistance | 3 | 2024 | 3964 | 0.430 |
Why?
|
Estrogens | 1 | 2019 | 1522 | 0.410 |
Why?
|
Glucagon | 1 | 2014 | 532 | 0.410 |
Why?
|
Depressive Disorder, Major | 2 | 2020 | 4762 | 0.410 |
Why?
|
Growth Hormone | 3 | 2023 | 569 | 0.400 |
Why?
|
Osteogenesis Imperfecta | 1 | 2011 | 81 | 0.370 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2024 | 2297 | 0.360 |
Why?
|
Renal Artery Obstruction | 1 | 2010 | 219 | 0.320 |
Why?
|
Lipid Metabolism | 2 | 2018 | 1902 | 0.320 |
Why?
|
Thyroid Diseases | 1 | 2011 | 386 | 0.310 |
Why?
|
Antidepressive Agents | 1 | 2020 | 2897 | 0.300 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2022 | 12149 | 0.290 |
Why?
|
Angioplasty | 1 | 2010 | 355 | 0.290 |
Why?
|
Cross-Sectional Studies | 12 | 2022 | 26129 | 0.270 |
Why?
|
Hypothyroidism | 1 | 2011 | 668 | 0.270 |
Why?
|
Critical Illness | 1 | 2019 | 2723 | 0.270 |
Why?
|
Carrier Proteins | 1 | 2019 | 4937 | 0.270 |
Why?
|
Adult | 27 | 2024 | 221210 | 0.260 |
Why?
|
Sternoclavicular Joint | 1 | 2006 | 32 | 0.260 |
Why?
|
Fibrosis | 2 | 2022 | 2049 | 0.240 |
Why?
|
Progesterone | 2 | 2019 | 742 | 0.230 |
Why?
|
Middle Aged | 23 | 2024 | 220921 | 0.220 |
Why?
|
Clavicle | 1 | 2006 | 224 | 0.220 |
Why?
|
Child Abuse | 1 | 2011 | 1077 | 0.210 |
Why?
|
Absorptiometry, Photon | 4 | 2022 | 1738 | 0.200 |
Why?
|
Female | 30 | 2024 | 392705 | 0.200 |
Why?
|
Somatostatin | 2 | 2020 | 447 | 0.190 |
Why?
|
Hepatitis | 1 | 2023 | 228 | 0.190 |
Why?
|
Humans | 38 | 2024 | 761596 | 0.180 |
Why?
|
Receptors, Somatotropin | 1 | 2020 | 58 | 0.180 |
Why?
|
Osteotomy | 1 | 2006 | 837 | 0.180 |
Why?
|
Multiple Endocrine Neoplasia Type 1 | 1 | 2020 | 43 | 0.170 |
Why?
|
Drug Therapy, Combination | 2 | 2020 | 6312 | 0.170 |
Why?
|
GABA Modulators | 1 | 2020 | 109 | 0.170 |
Why?
|
Pituitary-Adrenal Function Tests | 1 | 2019 | 30 | 0.170 |
Why?
|
Globulins | 1 | 2019 | 19 | 0.170 |
Why?
|
Receptor, IGF Type 1 | 1 | 2022 | 380 | 0.170 |
Why?
|
Double-Blind Method | 3 | 2024 | 12341 | 0.170 |
Why?
|
Follicular Phase | 1 | 2019 | 143 | 0.160 |
Why?
|
Luteal Phase | 1 | 2019 | 138 | 0.160 |
Why?
|
Aged | 13 | 2024 | 169310 | 0.160 |
Why?
|
Goserelin | 1 | 2019 | 126 | 0.160 |
Why?
|
Male | 22 | 2024 | 360846 | 0.160 |
Why?
|
Stents | 1 | 2010 | 3179 | 0.150 |
Why?
|
Joint Instability | 1 | 2006 | 801 | 0.150 |
Why?
|
Anti-Obesity Agents | 1 | 2021 | 227 | 0.150 |
Why?
|
Drug Monitoring | 2 | 2021 | 962 | 0.150 |
Why?
|
Intra-Abdominal Fat | 3 | 2021 | 613 | 0.150 |
Why?
|
Young Adult | 11 | 2024 | 59260 | 0.150 |
Why?
|
Hyperparathyroidism, Primary | 1 | 2020 | 163 | 0.150 |
Why?
|
Lipid Metabolism Disorders | 1 | 2017 | 20 | 0.150 |
Why?
|
Pregnancy Complications | 1 | 2011 | 2947 | 0.150 |
Why?
|
Fatty Liver | 1 | 2024 | 790 | 0.150 |
Why?
|
Body Mass Index | 4 | 2021 | 12953 | 0.140 |
Why?
|
Bone and Bones | 2 | 2022 | 2568 | 0.140 |
Why?
|
Gastrointestinal Agents | 1 | 2021 | 510 | 0.130 |
Why?
|
Disease Susceptibility | 1 | 2023 | 1787 | 0.130 |
Why?
|
Chromatography, Liquid | 1 | 2019 | 983 | 0.130 |
Why?
|
Adrenal Gland Diseases | 1 | 2016 | 141 | 0.130 |
Why?
|
Adipose Tissue | 4 | 2021 | 3313 | 0.120 |
Why?
|
Atherosclerosis | 1 | 2010 | 3407 | 0.120 |
Why?
|
Anti-Inflammatory Agents | 1 | 2024 | 1809 | 0.120 |
Why?
|
Sensitivity and Specificity | 3 | 2019 | 14665 | 0.120 |
Why?
|
Gyrus Cinguli | 1 | 2020 | 1115 | 0.110 |
Why?
|
Hormone Replacement Therapy | 1 | 2019 | 751 | 0.110 |
Why?
|
Adrenal Cortex Hormones | 1 | 2022 | 1881 | 0.110 |
Why?
|
Pneumocystis carinii | 1 | 2014 | 72 | 0.110 |
Why?
|
Iatrogenic Disease | 1 | 2016 | 540 | 0.110 |
Why?
|
Subcutaneous Fat | 1 | 2016 | 393 | 0.110 |
Why?
|
Tandem Mass Spectrometry | 1 | 2019 | 1188 | 0.110 |
Why?
|
Pneumonia, Pneumocystis | 1 | 2014 | 242 | 0.100 |
Why?
|
Aspirin | 1 | 2024 | 3133 | 0.100 |
Why?
|
Bone Diseases, Metabolic | 1 | 2016 | 409 | 0.100 |
Why?
|
Anxiety | 2 | 2017 | 4573 | 0.100 |
Why?
|
Pituitary-Adrenal System | 1 | 2015 | 552 | 0.100 |
Why?
|
Menopause | 1 | 2019 | 1646 | 0.100 |
Why?
|
Administration, Oral | 1 | 2019 | 4021 | 0.090 |
Why?
|
Lipids | 1 | 2022 | 3341 | 0.090 |
Why?
|
Maternal Welfare | 1 | 2011 | 112 | 0.090 |
Why?
|
Osteoporosis | 1 | 2021 | 1606 | 0.090 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2015 | 701 | 0.090 |
Why?
|
Postmenopause | 1 | 2020 | 2513 | 0.090 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2014 | 662 | 0.090 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2019 | 1723 | 0.090 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2016 | 1988 | 0.080 |
Why?
|
Molecular Imaging | 1 | 2016 | 815 | 0.080 |
Why?
|
Biopsy | 1 | 2021 | 6766 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2021 | 10766 | 0.080 |
Why?
|
Treatment Outcome | 4 | 2021 | 64685 | 0.080 |
Why?
|
Hypoglycemic Agents | 1 | 2021 | 3085 | 0.080 |
Why?
|
Gene Expression | 1 | 2021 | 7581 | 0.080 |
Why?
|
Kidney Function Tests | 1 | 2010 | 679 | 0.080 |
Why?
|
Follow-Up Studies | 5 | 2024 | 39106 | 0.070 |
Why?
|
Muscle, Skeletal | 2 | 2020 | 4948 | 0.070 |
Why?
|
Proto-Oncogene Proteins | 1 | 2020 | 4514 | 0.070 |
Why?
|
Sex Characteristics | 1 | 2018 | 2639 | 0.070 |
Why?
|
Employee Performance Appraisal | 1 | 2008 | 86 | 0.070 |
Why?
|
Reference Values | 1 | 2014 | 4920 | 0.070 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2017 | 6019 | 0.070 |
Why?
|
Pilot Projects | 1 | 2020 | 8633 | 0.070 |
Why?
|
Peptide Fragments | 1 | 2019 | 5112 | 0.070 |
Why?
|
Fetal Diseases | 1 | 2011 | 913 | 0.070 |
Why?
|
Specialty Boards | 1 | 2008 | 235 | 0.060 |
Why?
|
Professional Practice | 1 | 2008 | 313 | 0.060 |
Why?
|
Bone Nails | 1 | 2007 | 220 | 0.060 |
Why?
|
Thyroid Gland | 1 | 2011 | 1170 | 0.060 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 2850 | 0.060 |
Why?
|
Fracture Fixation | 1 | 2007 | 366 | 0.060 |
Why?
|
Certification | 1 | 2008 | 418 | 0.060 |
Why?
|
Fetus | 1 | 2011 | 1863 | 0.060 |
Why?
|
Radiography | 2 | 2014 | 6965 | 0.060 |
Why?
|
Humeral Fractures | 1 | 2007 | 282 | 0.060 |
Why?
|
Retrospective Studies | 5 | 2020 | 80647 | 0.060 |
Why?
|
Depressive Disorder | 1 | 2016 | 3728 | 0.050 |
Why?
|
Aging | 1 | 2022 | 8710 | 0.050 |
Why?
|
Prognosis | 3 | 2020 | 29629 | 0.050 |
Why?
|
Malpractice | 1 | 2008 | 556 | 0.050 |
Why?
|
Quality of Life | 2 | 2022 | 13367 | 0.050 |
Why?
|
Injury Severity Score | 1 | 2006 | 1045 | 0.050 |
Why?
|
Glomerular Filtration Rate | 1 | 2010 | 2178 | 0.050 |
Why?
|
Tendons | 1 | 2006 | 558 | 0.050 |
Why?
|
Cohort Studies | 2 | 2019 | 41495 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2016 | 20100 | 0.050 |
Why?
|
Adolescent | 6 | 2024 | 88326 | 0.050 |
Why?
|
Severity of Illness Index | 2 | 2017 | 15843 | 0.050 |
Why?
|
Linear Models | 1 | 2010 | 5872 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2016 | 14608 | 0.040 |
Why?
|
Diagnosis, Differential | 2 | 2014 | 12973 | 0.040 |
Why?
|
End Stage Liver Disease | 1 | 2024 | 352 | 0.040 |
Why?
|
Fractures, Bone | 1 | 2011 | 2046 | 0.040 |
Why?
|
Range of Motion, Articular | 1 | 2006 | 1588 | 0.040 |
Why?
|
Orthopedics | 1 | 2008 | 898 | 0.040 |
Why?
|
Arthroscopy | 1 | 2006 | 969 | 0.040 |
Why?
|
Ergolines | 1 | 2017 | 57 | 0.040 |
Why?
|
Developmental Disabilities | 1 | 2006 | 1509 | 0.040 |
Why?
|
Kidney Failure, Chronic | 1 | 2010 | 2472 | 0.040 |
Why?
|
Depression | 1 | 2017 | 8126 | 0.040 |
Why?
|
Obesity, Abdominal | 1 | 2021 | 374 | 0.040 |
Why?
|
Survival Analysis | 1 | 2010 | 10090 | 0.040 |
Why?
|
Autistic Disorder | 1 | 2006 | 1220 | 0.040 |
Why?
|
Administration, Topical | 1 | 2019 | 704 | 0.030 |
Why?
|
HIV-1 | 1 | 2014 | 6863 | 0.030 |
Why?
|
Lipodystrophy | 1 | 2017 | 145 | 0.030 |
Why?
|
Proportional Hazards Models | 1 | 2010 | 12463 | 0.030 |
Why?
|
Pain Measurement | 1 | 2006 | 3551 | 0.030 |
Why?
|
Peptides, Cyclic | 1 | 2017 | 392 | 0.030 |
Why?
|
Lung | 1 | 2014 | 10002 | 0.030 |
Why?
|
Recovery of Function | 1 | 2006 | 2979 | 0.030 |
Why?
|
Disease Progression | 2 | 2023 | 13510 | 0.030 |
Why?
|
Aromatase Inhibitors | 1 | 2019 | 513 | 0.030 |
Why?
|
Body Weight | 2 | 2016 | 4618 | 0.030 |
Why?
|
Risk Assessment | 1 | 2016 | 23996 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 3 | 2021 | 20568 | 0.030 |
Why?
|
Down-Regulation | 1 | 2021 | 2919 | 0.030 |
Why?
|
Spine | 1 | 2021 | 1118 | 0.030 |
Why?
|
Gonadal Steroid Hormones | 1 | 2017 | 702 | 0.030 |
Why?
|
Recurrence | 1 | 2006 | 8466 | 0.030 |
Why?
|
Sweating | 1 | 2014 | 155 | 0.030 |
Why?
|
Patient Satisfaction | 1 | 2006 | 3462 | 0.030 |
Why?
|
Prednisone | 1 | 2017 | 1563 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 36426 | 0.030 |
Why?
|
Parents | 1 | 2006 | 3563 | 0.030 |
Why?
|
Amenorrhea | 1 | 2016 | 483 | 0.030 |
Why?
|
Nutrition Surveys | 1 | 2020 | 1733 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2018 | 15502 | 0.030 |
Why?
|
Up-Regulation | 1 | 2021 | 4125 | 0.030 |
Why?
|
Clinical Competence | 1 | 2008 | 4793 | 0.020 |
Why?
|
Estradiol | 1 | 2019 | 1937 | 0.020 |
Why?
|
Premenopause | 1 | 2016 | 1039 | 0.020 |
Why?
|
Androgens | 1 | 2019 | 1286 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2020 | 58984 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2021 | 2095 | 0.020 |
Why?
|
Mass Screening | 1 | 2006 | 5429 | 0.020 |
Why?
|
Adiposity | 1 | 2021 | 1879 | 0.020 |
Why?
|
Odds Ratio | 1 | 2023 | 9647 | 0.020 |
Why?
|
Chronic Disease | 1 | 2006 | 9319 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2019 | 1520 | 0.020 |
Why?
|
Pregnancy | 1 | 2011 | 29890 | 0.020 |
Why?
|
Causality | 1 | 2016 | 1242 | 0.020 |
Why?
|
Infant | 1 | 2011 | 36193 | 0.020 |
Why?
|
Governing Board | 1 | 2008 | 50 | 0.020 |
Why?
|
HIV Infections | 1 | 2014 | 17354 | 0.020 |
Why?
|
Physician Impairment | 1 | 2008 | 72 | 0.020 |
Why?
|
Anti-Infective Agents | 1 | 2014 | 983 | 0.020 |
Why?
|
Fever | 1 | 2014 | 1618 | 0.020 |
Why?
|
Dyspnea | 1 | 2014 | 1347 | 0.020 |
Why?
|
Time Factors | 1 | 2006 | 39969 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10774 | 0.010 |
Why?
|
Blood Glucose | 1 | 2017 | 6391 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9327 | 0.010 |
Why?
|
Risk Factors | 2 | 2021 | 74213 | 0.010 |
Why?
|
Oxygen | 1 | 2014 | 4227 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16592 | 0.010 |
Why?
|
Early Diagnosis | 1 | 2006 | 1186 | 0.010 |
Why?
|
Comorbidity | 1 | 2016 | 10508 | 0.010 |
Why?
|
Child | 2 | 2007 | 80158 | 0.010 |
Why?
|
Social Behavior | 1 | 2006 | 1135 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2017 | 22176 | 0.010 |
Why?
|
Prevalence | 1 | 2016 | 15733 | 0.010 |
Why?
|
Mice | 1 | 2023 | 81539 | 0.010 |
Why?
|
Mutation | 1 | 2020 | 30053 | 0.010 |
Why?
|
Hospitals | 1 | 2008 | 3883 | 0.010 |
Why?
|
Child, Preschool | 2 | 2007 | 42232 | 0.010 |
Why?
|
Cognition Disorders | 1 | 2006 | 3980 | 0.010 |
Why?
|
Animals | 1 | 2023 | 168475 | 0.010 |
Why?
|
Age Factors | 1 | 2006 | 18399 | 0.010 |
Why?
|
Prospective Studies | 1 | 2007 | 54423 | 0.000 |
Why?
|